Thermo Fisher Scientific (TMO) Net Cash Flow Growth (1y) (2010 - 2026)
Thermo Fisher Scientific (TMO) Net Cash Flow Growth (1y) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 209.29 Bn | 205.35 Bn | 8.34 Bn | 498.33% |
| 2 | Danaher | 137.39 Bn | 133.06 Bn | 3.61 Bn | -260.86% |
| 3 | Idexx Laboratories | 46.84 Bn | 46.64 Bn | 779.09 Mn | 73.93% |
| 4 | Agilent Technologies | 39.29 Bn | 37.48 Bn | 990.00 Mn | 722.22% |
| 5 | Natera | 39.28 Bn | 38.18 Bn | 696.04 Mn | -58.16% |
| 6 | Iqvia Holdings | 37.90 Bn | 35.95 Bn | 1.44 Bn | -115.29% |
| 7 | Illumina | 30.65 Bn | 29.49 Bn | 770.00 Mn | 73.12% |
| 8 | Mettler Toledo International | 28.92 Bn | 28.87 Bn | 650.22 Mn | -441.96% |
| 9 | Quest Diagnostics | 25.96 Bn | 25.64 Bn | 1.03 Bn | 84.25% |
| 10 | Labcorp Holdings | 25.71 Bn | 24.73 Bn | 1.01 Bn | 138.88% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 27, 2026 | 498.33% |
| Mar 28, 2026 | -7,202.13% |
| Dec 31, 2025 | 2,311.80% |
| Sep 27, 2025 | 3.31% |
| Jun 28, 2025 | -92.46% |
| Mar 29, 2025 | 103.62% |
| Dec 31, 2024 | -118.55% |
| Sep 28, 2024 | -184.26% |
| Jun 29, 2024 | 543.45% |
| Mar 30, 2024 | 48.06% |
| Dec 31, 2023 | -64.15% |
| Sep 30, 2023 | 148.83% |
| Jul 1, 2023 | 54.90% |
| Apr 1, 2023 | -210.35% |
| Dec 31, 2022 | 168.91% |
| Oct 1, 2022 | -75.54% |
| Jul 2, 2022 | -152.20% |
| Apr 2, 2022 | 66.88% |
| Dec 31, 2021 | -391.59% |
| Oct 2, 2021 | 226.93% |